Dataset Information


ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.

ABSTRACT: Cancer cells are characterized by aberrant epigenetic landscapes and often exploit chromatin machinery to activate oncogenic gene expression programs. Recognition of modified histones by 'reader' proteins constitutes a key mechanism underlying these processes; therefore, targeting such pathways holds clinical promise, as exemplified by the development of bromodomain and extra-terminal (BET) inhibitors. We recently identified the YEATS domain as an acetyl-lysine-binding module, but its functional importance in human cancer remains unknown. Here we show that the YEATS domain-containing protein ENL, but not its paralogue AF9, is required for disease maintenance in acute myeloid leukaemia. CRISPR-Cas9-mediated depletion of ENL led to anti-leukaemic effects, including increased terminal myeloid differentiation and suppression of leukaemia growth in vitro and in vivo. Biochemical and crystal structural studies and chromatin-immunoprecipitation followed by sequencing analyses revealed that ENL binds to acetylated histone H3, and co-localizes with H3K27ac and H3K9ac on the promoters of actively transcribed genes that are essential for leukaemia. Disrupting the interaction between the YEATS domain and histone acetylation via structure-based mutagenesis reduced the recruitment of RNA polymerase II to ENL-target genes, leading to the suppression of oncogenic gene expression programs. Notably, disrupting the functionality of ENL further sensitized leukaemia cells to BET inhibitors. Together, our data identify ENL as a histone acetylation reader that regulates oncogenic transcriptional programs in acute myeloid leukaemia, and suggest that displacement of ENL from chromatin may be a promising epigenetic therapy, alone or in combination with BET inhibitors, for aggressive leukaemia.

PROVIDER: S-EPMC5372383 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2017-04-05 | GSE80774 | GEO
2017-02-23 | GSE80779 | GEO
| S-EPMC7061414 | BioStudies
| S-EPMC5828395 | BioStudies
| S-EPMC5497220 | BioStudies
| S-EPMC6503841 | BioStudies
| S-EPMC8161486 | BioStudies
| S-EPMC5995911 | BioStudies
| S-EPMC7384521 | BioStudies
| S-EPMC4573853 | BioStudies